首页|Second People's Hospital of Yunnan Province Reports Findings in Gastric Cancer (Evaluation of enhanced recovery after surgery for gastric cancer patients undergoing gastrectomy: a systematic re- view and meta-analysis)
Second People's Hospital of Yunnan Province Reports Findings in Gastric Cancer (Evaluation of enhanced recovery after surgery for gastric cancer patients undergoing gastrectomy: a systematic re- view and meta-analysis)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
2024 FEB 02 (NewsRx) – By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Oncology - Gastric Cancer is the subject of a report. According to news reporting from Qujing, People’s Republic of China, by NewsRx journalists, research stated, “For complicated surgical patients, enhanced recovery after surgery (ERAS) decreases stress and hospital stays. It accelerates recovery and lowers readmissions, morbidity, and death.” The news correspondents obtained a quote from the research from the Second People’s Hospital of Yunnan Province, “ERAS’s effectiveness in stomach cancer laparoscopic-assisted gastrectomy (LAG) or robotic gastrectomy is still debated. This study assesses the efficacy and safety of the ERAS program for patients undergoing gastrectomy for gastric cancer. PRISMA-compliant searches were performed in Medline, Embase, PubMed, the Web of Sciences, and the Cochrane Library databases until March 2023. The search included articles that compared ERAS protocol results for gastric cancer surgery patients to conventional care. RevMan performed meta-analysis, and the Cochrane Risk of Bias Assessment Tool assessed study quality. This meta-analysis contained 11 carefully chosen randomized controlled trials (RCTs) involving 1790 people. The ERAS group had 902 participants, while the traditional care group had 888. The ERAS group had a shorter post-operative hospital stay, with a weighted mean difference (WMD) of -1.12 days (95% CI: -1.89 to -0.35, p = 0.00001), I = 89%, and a lower number of patients with post-operative problems, with an odds ratio (OR) of 0.73 (95% CI: 0.55 to 0.97; p = 0.03), I = 60%.”
QujingPeople’s Republic of ChinaAsiaCancerDigestive Sys- tem Surgical ProceduresEmerging TechnologiesGastrectomyGastric CancerGastroenterologyHealth and MedicineHospitalsMachine LearningOncologyRoboticsRobotsSurgery
NETL
NSTL
